SELLAS raises $23.6M via warrant exercise; issues new 5.5-yr warrants at $1.88 strike

SELLAS Life Sciences Group, Inc.

Existing warrant holder cash exercises 19,685,040 shares at $1.20, yielding $23.6M gross proceeds.
In exchange, company issues new unregistered warrants to buy same number of shares at $1.88 (closing price Sep 10).
New warrants exercisable immediately, expire 5.5 years from issuance; resale registration statement to be filed within 30 days.
Company pays aggregate fee of 6.5% of gross proceeds to A.G.P. and Maxim Group as financial advisors.
90-day lock-up on share issuance and 12-month ban on variable-rate transactions included in inducement agreement.

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

SELLAS Life Sciences Group, Inc. issued up to 19,685,040 shares of Common Stock of warrant to a holder for in consideration of the Holder’s agreement to exercise the Existing Warrants.

Security: warrant
Shares: up to 19,685,040 shares of Common Stock
Purchaser: a holder
Consideration: in consideration of the Holder’s agreement to exercise the Existing Warrants

Exact text from the filing

Pursuant to the Inducement Agreement, the Holder and the Company agreed that, subject to any applicable beneficial ownership limitations, the Holder would cash exercise 19,685,040 shares of Common Stock at an exercise price of $1.20 per share

View on SEC.gov

172 equity issuances filed in the last 30 days. Browse all equity issuances →

SELLAS Life Sciences Group, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-25-089272

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.